Open AccessImpact of a Patient Support Program on Patient Beliefs About Neovascular Age-Related Macular Degeneration and Persistence to Anti-Vascular Endothelial Growth Factor Therapy
Author(s) -
Andrew Chang,
John Stokes,
Lindy Priestman,
Connor Holmes,
Peter Said
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s293941
Subject(s) - medicine , discontinuation , macular degeneration , persistence (discontinuity) , aflibercept , ranibizumab , medical prescription , proportional hazards model , cohort , pediatrics , ophthalmology , physical therapy , bevacizumab , pharmacology , geotechnical engineering , chemotherapy , engineering
This study aimed to compare persistence between patients prescribed intravitreal aflibercept (IVT-AFL) for neovascular age-related macular degeneration (nAMD) in Australia enrolled on a patient support program (PSP) with that of a sample of patients from the Australian Pharmaceutical Benefits Scheme (PBS) dataset (10% PBS sample); explore predictors of persistence; describe changes in patient beliefs over the course of their enrollment in a PSP for patients treated with IVT-AFL for nAMD; and assess patient satisfaction.